Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Can nucleic acid testing reimburse medical insurance?
Can nucleic acid testing reimburse medical insurance?
Legal analysis: medical insurance can only be reimbursed to those who should be examined.

I. People to be tested The people to be tested mentioned here refer to such people who are required by the hospital to do nucleic acid testing and can be included in the medical insurance diagnosis and treatment project catalogue according to regulations, and the expenses are paid by medical insurance. These people who are required to do nucleic acid testing go to fever clinics, or newly hospitalized patients and caregivers. The expenses incurred by these people can be reimbursed through medical insurance.

Second, people who are willing to test here refer to those who voluntarily ask for nucleic acid testing, not because of diseases and other factors or hospital requirements, such as the need to travel or not feel at ease. In this case, the person being tested can't use medical insurance to pay, and needs to bear the testing expenses at his own expense.

Legal basis: In the Notice on Further Consolidating the Achievements and Improving the Prevention, Control and Treatment Ability of COVID-19 in Medical Institutions, the Comprehensive Group of the State Council novel coronavirus Epidemic Prevention and Control Mechanism clearly stipulates that COVID-19 infection cannot be ruled out after consultation and physical examination, and the detection and screening of COVID-19 nucleic acid in patients with fever and patients with high suspected COVID-19 infection in outpatient and emergency departments should be completed in an appropriate way before the patients are admitted to hospital, so as to find COVID-19 infected people in time. These people can apply for medical insurance for nucleic acid testing.